Pharmazz and Sun Pharmaceutical Industries Enter into Agreement

Pharmazz has entered into a licence agreement with Sun Pharmaceutical Industries to introduce Tyvalzi™ (Sovateltide) in India.

Under the terms of the agreement, Sun Pharma has been granted the rights to market Sovateltide in India, utilising the brand name Tyvalzi™ (Sovateltide). In return, Pharmazz will receive upfront and milestone payments, including royalties.

Tyvalzi™ is a new drug designed to address acute cerebral ischaemic stroke, a condition characterised by the interruption of blood supply to the brain, leading to potential brain damage, neurological deficits, or even death.

The mechanism of action of Tyvalzi™ involves the promotion of neurovascular remodelling, including the formation of new neurons (neurogenesis) and blood vessels (angiogenesis). Additionally, it offers protection to neural mitochondria and enhances their biogenesis.

Sovateltide (Tyvalzi™) has been approved as a new, effective, and well-tolerated therapy for treating patients with cerebral ischaemic stroke. It has shown statistically significant and clinically meaningful improvements in neurological outcomes.

Currently, there have been no new drugs approved for the treatment of stroke in over two decades, aside from rTPA. Sovateltide (Tyvalzi™), as a selective endothelin B receptor agonist, represents a groundbreaking development and can be administered up to 24 hours following a cerebral ischaemic stroke.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!